Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Roland Diggelmann, Victor Esch, Scott Hutton, David Brunel, More

Accelerate Diagnostics: Roland Diggelmann

Roland Diggelmann has been appointed to Accelerate Diagnostics' board of directors. Diggelmann is currently CEO of Smith+Nephew, a British medical equipment manufacturing company, having recently succeeded Namal Nawana, the former CEO of Alere. Diggelmann previously served as CEO of Roche Diagnostics, and also worked in the orthopedics sector at Sulzer Orthopedics and Zimmer Group.


Armonica Technologies: Victor Esch

Armonica Technologies, an Albuquerque, New Mexico-based firm developing long-read DNA sequencing technology, has appointed Victor Esch as president and CEO. Esch has more than twenty years of executive and technical experience in the medical device industry, including as CEO of DNA Electronics and CEO of nanoMR, which DNA Electronics acquired in 2015. Esch was a founder of Powervision, which was acquired by Alcon in 2019. He also previously served as chief technology officer for EndoVasix.


Biodesix: Scott Hutton, David Brunel 

Biodesix announced Scott Hutton will become the firm's CEO, effective Jan. 1, 2020. Current CEO David Brunel will become the chairman and will continue in a day-to-day advisory capacity assisting with strategic direction and key partnerships, the company said. He is a cofounder of Biodesix and has led the firm for more than 13 years.


For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.